Text Size
10 studies found for:    Antioxidant | Open Studies | Exclude Unknown | NCCAM

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
Condition: Anemia, Sickle Cell
Intervention: Drug: alpha-lipoic acid and acetyl-L-carnitine
2 Recruiting Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Oxidative Stress
Interventions: Drug: silymarin;   Dietary Supplement: green tea extract (EGCG)
3 Recruiting N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Proteinuria;   Oxidative Stress
Interventions: Dietary Supplement: N-acetylcysteine;   Dietary Supplement: silibin;   Dietary Supplement: high-dose silibin;   Dietary Supplement: N-acetylcysteine placebo;   Dietary Supplement: silibin placebo
4 Recruiting CoQ10 Biomarker Trial
Conditions: Oxidative Stress;   Inflammation;   Endothelial Dysfunction
Interventions: Dietary Supplement: Coenzyme Q10;   Dietary Supplement: Placebo
5 Recruiting Lipoic Acid and Prevention of Heart Disease
Condition: Atherosclerosis
Interventions: Dietary Supplement: R-alpha lipoic acid;   Dietary Supplement: Placebo
6 Recruiting Melatonin and Nighttime Blood Pressure in African Americans
Condition: Hypertension
Interventions: Drug: 8 mg time-release melatonin pills;   Drug: Placebo pills
7 Recruiting Glutathione in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Proteinuria;   Oxidative Stress
Interventions: Drug: N-acetylcysteine placebo + silibin placebo;   Drug: N-acetylcysteine active + silibin placebo;   Drug: N-acetylcysteine placebo + silibin active;   Drug: N-acetylcysteine active + silibin active;   Drug: N-acetylcysteine active + high-dose silibin active
8 Recruiting The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease
Condition: Atherosclerosis
Intervention: Dietary Supplement: Crossover of R-alpha lipoic acid and placebo
9 Recruiting Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study
Condition: Hypertension
Interventions: Drug: 24 mg time release melatonin;   Drug: Placebo
10 Recruiting Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals
Condition: HIV Infection
Intervention: Drug: Polyphenon E
To Top

† Indicates status has not been verified in more than two years